Viewing StudyNCT00511823



Ignite Creation Date: 2024-05-05 @ 6:36 PM
Last Modification Date: 2024-10-26 @ 9:35 AM
Study NCT ID: NCT00511823
Status: COMPLETED
Last Update Posted: 2017-08-03
First Post: 2007-08-02

Brief Title: The Pharmacokinetic Interaction Between Oral Casopitant and Oral Dolasetron Granisetron or Rosiglitazone in Subjects
Sponsor: GlaxoSmithKline
Organization: GlaxoSmithKline

Conditions & Keywords Data

Conditions:
Name
Nausea and Vomiting Chemotherapy-Induced
Keywords:
Name View
casopitant View
drug-drug interaction View
rosiglitazone View
safety View
CYP2C8 View
pharmacokinetics View
CYP3A4 View
granisetron View
dolasetron View
CYP2D6 View